Thank you very much, Chair.
I’d like to thank the witnesses for being here.
My questions will focus mainly on replacing the CP-140 Aurora, and are addressed to Mr. Page. In particular, they relate to the testimony provided three weeks ago, on October 17th, before the Standing Committee on Government Operations and Estimates.
My first question has to do with the mandate given to Avascent, which was to provide information on replacement products for CP-140s.
When was Avascent given the mandate to review the options?